HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuo Li Selected Research

AIS 48

11/2020Application of lung ultrasonography in critically ill patients with COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuo Li Research Topics

Disease

91Neoplasms (Cancer)
08/2022 - 09/2008
30Infections
01/2022 - 04/2007
28Inflammation (Inflammations)
08/2022 - 08/2009
17Neoplasm Metastasis (Metastasis)
01/2022 - 03/2014
15Breast Neoplasms (Breast Cancer)
12/2021 - 07/2014
11Hypoxia (Hypoxemia)
10/2022 - 09/2008
11Pain (Aches)
10/2022 - 05/2014
11Adenocarcinoma
04/2022 - 01/2017
11Stroke (Strokes)
01/2022 - 04/2018
11Ischemic Stroke
01/2022 - 01/2018
11Alzheimer Disease (Alzheimer's Disease)
10/2021 - 10/2010
10Stomach Neoplasms (Stomach Cancer)
01/2022 - 03/2016
10Hepatocellular Carcinoma (Hepatoma)
07/2020 - 07/2014
9Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 12/2015
8Lung Neoplasms (Lung Cancer)
01/2022 - 10/2010
8Carcinogenesis
01/2022 - 11/2013
7Asthma (Bronchial Asthma)
10/2022 - 07/2003
7Atrial Fibrillation
07/2022 - 01/2016
7Nasopharyngeal Carcinoma
03/2022 - 11/2013
7Virus Diseases (Viral Diseases)
10/2021 - 04/2007
6Necrosis
06/2022 - 09/2008
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2020
6Fibrosis (Cirrhosis)
10/2021 - 01/2016
6Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 10/2003
6Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2014
5COVID-19
01/2022 - 09/2020
5Obesity
06/2021 - 08/2009
5Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 06/2015
5Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 08/2012
5Lymphatic Metastasis
07/2019 - 08/2015
4Multiple Sclerosis
12/2022 - 11/2015
4Liver Cirrhosis (Hepatic Cirrhosis)
08/2022 - 01/2018
4Ovarian Neoplasms (Ovarian Cancer)
04/2022 - 08/2015
4Fatty Liver
12/2021 - 08/2013
4Esophageal Squamous Cell Carcinoma
01/2020 - 11/2013
4Infarction (Infarctions)
01/2020 - 06/2014
3Liver Diseases (Liver Disease)
08/2022 - 10/2003
3Cardiac Arrhythmias (Arrythmia)
07/2022 - 03/2016
3Disease Progression
06/2022 - 04/2018
3Chronic Kidney Failure (Chronic Renal Failure)
05/2022 - 02/2017
3Bacterial Infections (Bacterial Infection)
03/2022 - 10/2018
3Postoperative Pain
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2009
23Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2012
14CytokinesIBA
10/2022 - 02/2010
13Messenger RNA (mRNA)IBA
01/2022 - 10/2013
12MicroRNAs (MicroRNA)IBA
01/2021 - 11/2013
11EnzymesIBA
10/2021 - 09/2008
10Pharmaceutical PreparationsIBA
06/2022 - 05/2014
7Therapeutic UsesIBA
10/2022 - 08/2013
7VaccinesIBA
07/2022 - 01/2015
7AntigensIBA
01/2022 - 04/2007
7LipidsIBA
01/2021 - 01/2014
6Fatty Acids (Saturated Fatty Acids)IBA
10/2022 - 01/2014
6Long Noncoding RNAIBA
01/2022 - 06/2017
6Glucose (Dextrose)FDA LinkGeneric
12/2021 - 01/2019
6DNA (Deoxyribonucleic Acid)IBA
07/2021 - 10/2013
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022 - 09/2008
5Contrast MediaIBA
06/2022 - 12/2018
5CollagenIBA
01/2022 - 01/2017
5Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 02/2013
5Interleukin-6 (Interleukin 6)IBA
01/2021 - 09/2008
5CholesterolIBA
12/2020 - 10/2003
5Histones (Histone)IBA
01/2019 - 11/2015
4Bronchodilator Agents (Bronchodilators)IBA
10/2022 - 11/2005
4Circular RNAIBA
01/2021 - 01/2020
4Biological ProductsIBA
01/2021 - 03/2015
4Interleukin-10 (Interleukin 10)IBA
01/2021 - 01/2011
4Indicators and Reagents (Reagents)IBA
01/2021 - 05/2016
4Adenosine Triphosphate (ATP)IBA
11/2020 - 08/2015
4Cisplatin (Platino)FDA LinkGeneric
03/2020 - 03/2013
4Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 08/2015
4Freund's AdjuvantIBA
01/2017 - 09/2008
4Caspase 3 (Caspase-3)IBA
11/2015 - 03/2013
3CarrageenanIBA
10/2022 - 02/2021
3InterferonsIBA
10/2022 - 10/2018
3Epoxide HydrolasesIBA
10/2022 - 02/2021
3Antiviral Agents (Antivirals)IBA
10/2022 - 04/2007
34- (4- (3- adamantan- 1- ylureido)cyclohexyloxy)benzoic acidIBA
10/2022 - 02/2021
3LigandsIBA
01/2022 - 03/2015
3Peptides (Polypeptides)IBA
01/2022 - 04/2007
3hydroxide ionIBA
01/2022 - 01/2017
3Rifampin (Rifampicin)FDA LinkGeneric
01/2022 - 04/2015
3Cell-Free Nucleic AcidsIBA
01/2022 - 01/2020
3Small Interfering RNA (siRNA)IBA
01/2022 - 04/2018
3Analgesics (Analgesic Drugs)IBA
01/2022 - 01/2017
3Untranslated RNA (Noncoding RNA)IBA
01/2022 - 01/2020
3hepsinIBA
11/2021 - 01/2020
3AntioxidantsIBA
10/2021 - 10/2017
3RNA (Ribonucleic Acid)IBA
05/2021 - 01/2019

Therapy/Procedure

42Therapeutics
08/2022 - 02/2010
10Drug Therapy (Chemotherapy)
01/2022 - 08/2015
9Neoadjuvant Therapy
01/2022 - 01/2019
8Immunotherapy
01/2022 - 02/2010
4Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 05/2014
4Gastrectomy
04/2022 - 09/2020
4Radiotherapy
05/2021 - 09/2008
3Lasers (Laser)
10/2022 - 12/2017
3Aftercare (After-Treatment)
03/2022 - 01/2016
3Length of Stay
01/2022 - 09/2020